Note 10. Share-based Compensation:

During the nine months ended March 31, 2025 and 2024, the Company granted 0.8 million and 1.0 million stock options at weighted average grant prices of $74.63 and $80.07 and weighted average fair values of $25.44 and $27.47, respectively. During the nine months ended March 31, 2025 and 2024, the Company granted 0.5 million and 0.4 million restricted stock units at a weighted average fair value of $74.95 and $78.41, respectively. During the nine months ended March 31, 2025 and 2024, the Company granted 12,736 and 27,196 shares of restricted common stock shares at a weighted average fair value of $68.67 and $56.98, respectively.

Stock options for 1.1 million and 1.6 million shares of common stock with total intrinsic values of $35.7 million and $73.1 million were exercised during the nine months ended March 31, 2025 and 2024, respectively.

​

Stock-based compensation expense, inclusive of payroll taxes, of $11.2 million and $8.1 million was included in selling, general and administrative expenses for the quarter ended March 31, 2025 and 2024, respectively. Stock-based compensation expenses, inclusive of payroll taxes, of $36.0 million and $31.7 million was included in selling, general, and administrative expenses for the nine months ended March 31, 2025 and 2024, respectively. Additionally, the Company recognized $0.4 million and $1.0 million of stock-based compensation costs in cost of goods sold in the quarter and nine months ended March 31, 2025, respectively, compared to $0.1 million and $0.6 million in cost of goods sold in the comparative prior year periods. As of March 31, 2025, there was $50.7 million of unrecognized compensation cost related to non-vested stock options, non-vested restricted stock units and non-vested restricted stock. The weighted average period over which the compensation cost is expected to be recognized is 2.0 years.

The Company recorded expense from the 2014 Employee Stock Purchase Plan (ESPP) was not material for the quarter ended March 31, 2025 and 2024. The Company recorded expense of $0.4 million and $0.5 million for the nine months ended March 31, 2025 and 2024, respectively.